Seizure News and Research

Latest Seizure News and Research

Antiepileptic drug Levetiracetam may help patients with Parkinson's disease

In patients with Parkinson's disease, the antiepileptic drug levetiracetam (Keppra(R)) reduced the involuntary movements (dyskinesia) associated with levodopa, the medication most commonly used to treat Parkinson's disease, according to a study presented today at the 56th annual meeting of the American Academy of Neurology.

29 Apr 2004

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Two studies presented today at the American Academy of Neurology (AAN) 56th Annual Meeting show that pregabalin, when used as an add-on treatment for epilepsy, does not affect male reproductive function or interfere with the effectiveness of oral contraceptives.

29 Apr 2004

Two outbreaks in humans of deadly Nipah virus in reported Bangladesh

Wildlife Trust's Consortium for Conservation Medicine reports that the World Health Organization (WHO) has now confirmed two recent outbreaks in humans of deadly Nipah virus in Bangladesh. The Consortium has been researching the origins of Nipah virus under a grant from the National Institutes of Health.

28 Apr 2004

People with uncontrolled epilepsy have low levels of a certain fatty acid

Omega-3 fatty acids are crucial to the proper development and function of cell membranes in the brain. But one particular fatty acid, docosahexaenoic acid (DHA), is found at abnormally low levels in patients with uncontrolled epilepsy, according to researchers at Emory University in Atlanta, GA.

28 Apr 2004

Antiepileptic drug levetiracetam (Keppra) shown to help chronic daily headaches

The antiepileptic drug levetiracetam (Keppra(R)) significantly reduced the frequency and impact of headaches in patients diagnosed with transformed migraine, according to a new study presented today at the 56th annual meeting of the American Academy of Neurology (AAN).

27 Apr 2004

A ten year study shows that surgery is not only effective, but the preferred treatment for select epilepsy patients

A study of ten years of patient outcomes shows that surgery is not only effective, but the preferred treatment for select epilepsy patients. In the most comprehensive study of long-term surgery success rates, Mayo Clinic physicians report that 73 percent of 491 Mayo Clinic patients were either seizure-free or experienced seizures only when medication was discontinued.

27 Apr 2004

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.

26 Apr 2004

NICE issues guidance on use of newer drugs for epilepsy in adults

The National Institute for Clinical Excellence (NICE) has today issued guidance to the NHS in England and Wales on the use of newer drugs for the treatment of epilepsy in adults.

26 Apr 2004

Foreign drug repackager complies with FDA order

The Food and Drug Administration today announced the settlement of a court case against an Illinois firm involved last year in FDA's seizure of thousands of imported unapproved drugs, including those that were labeled in foreign languages and/or labeled as repacked.

13 Apr 2004

FDA issues warning againts street drug alternatives

FDA issued a warning in February 2004, about adverse events experienced by four teenagers after they consumed Green Hornet Liquid that contained high levels of the over-the-counter drugs diphenhydramine and dextromethorphan.

11 Apr 2004

Natural medication shown to not always be a safe alternative to synthetic medication

The common perception that if medication is natural then it must be safe has recently come under fire from a researh by a Consumer Reports magazine. The consumer publication found a dozen herbal supplements, some banned in Asia, Europe and Canada but widely available in the United States, may cause cancer, kidney or liver damage and even death.

10 Apr 2004

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

The largest study of its kind, designed to track the development of Creutzfeldt-Jakob disease in people who received human growth hormone from cadavers, has found that the vast majority of those who received the hormone did not contract the fatal condition. However, some recipients (26 out of approximately 7,700) did develop the disease.

7 Apr 2004

New research findings in study of Rett Syndrome

Rudolf Jaenisch of the Whitehead Institute of Biomedical Research in Cambridge, MA reports in the April 6, 2004 online issue of the Proceedings of the National Academy of Sciences that introduction of the MeCP2 protein into post-mitotic nerve cells of MeCP2 mutant mice rescues the symptoms of Rett Syndrome. This raises the possibility that neurons are functionally normal in a newborn child and that neural dysfunction manifests itself only later due to prolonged MeCP2 deficiency. If correct, therapeutic strategies aimed at preventing the onset of Rett symptoms could be initiated at birth.

7 Apr 2004

New Australian collaboration to discover new drugs targeting epilepsy and anxiety

Bionomics Limited and Southern Cross University announced today that they had established a collaboration to discover new drugs targeting epilepsy and anxiety. Under the arrangement, Southern Cross University will provide Bionomics with extracts from its collection of Australian-based natural products, together with expertise in natural products chemistry.

30 Mar 2004

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

St. John’s wort, an herb thought to be a safe, natural remedy for mild depression, may interfere with a powerful cancer-fighting drug’s ability to prevent relapse in leukemia patients, a University of Florida pharmacy researcher will report March 27 at the annual meeting of the American Society for Clinical Pharmacology and Therapeutics.

26 Mar 2004

Discovery of new gene sheds light on human brain development

With the identification of the gene responsible for a newly recognized type of mental retardation, researchers at Beth Israel Deaconess Medical Center (BIDMC) have also discovered what appears to be the key target in the evolution of the frontal lobes of the brain's cerebral cortex. The findings offer a key insight into the complex puzzle of human brain development - and the evolution of human behavior.

25 Mar 2004

Researchers discover new form of the Rett syndrome protein

Adrian Bird and Skirmantas Kriaucionis of the University of Edinburgh have discovered a novel form of the protein MeCP2. This alternate form, coined MeCP2 alpha, differs from the original only in the first 19 amino acids. Interestingly, Adrian Bird, Director of the Welcome Trust Centre for Cell Biology at Edinburgh University, found that MeCP2 alpha, is ten times more prevalent not only in the brain but also in other tissues. These findings are currently reported online in Nucleic Acids Research. Similar findings were reported yesterday in Nature Genetics online by Berge Minassian, a neurologist and scientist at Toronto's Hospital for Sick Children.

22 Mar 2004

Clinical study - Diagnostic testing for epilepsy released

Bionomics Limited announced today the publication of its international clinical study involving patients with a form of epilepsy confined to early childhood in the scientific journal, Annals of Neurology. The publication details genes associated with a condition known as Benign Familial Neonatal Infantile Spasms (BFNIS), a condition in which infants experience seizures in the first few months of their life.

22 Mar 2004

Seizure News and Research

Latest Seizure News and Research

Antiepileptic drug Levetiracetam may help patients with Parkinson's disease

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Two outbreaks in humans of deadly Nipah virus in reported Bangladesh

People with uncontrolled epilepsy have low levels of a certain fatty acid

Antiepileptic drug levetiracetam (Keppra) shown to help chronic daily headaches

A ten year study shows that surgery is not only effective, but the preferred treatment for select epilepsy patients

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

NICE issues guidance on use of newer drugs for epilepsy in adults

Foreign drug repackager complies with FDA order

FDA issues warning againts street drug alternatives

Natural medication shown to not always be a safe alternative to synthetic medication

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

New research findings in study of Rett Syndrome

New Australian collaboration to discover new drugs targeting epilepsy and anxiety

St. John’s wort may interfere with cancer-fighting drug’s ability to prevent relapse in leukemia patients

Discovery of new gene sheds light on human brain development

Researchers discover new form of the Rett syndrome protein

Clinical study - Diagnostic testing for epilepsy released

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Seizure News and Research

Latest Seizure News and Research

Arrayed CRISPR Screening for Revolutionizing Target Discovery

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Newsletters you may be interested in